If you wish to find out more, or do not consent to the use of all or some cookies,
Please note that effective as of 1 August 2017 Alfa Wassermann S.p.A., Biofutura Pharma S.p.A. and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (collectively, the “Merged Companies”) merged into Alfasigma S.p.A. ( “Alfasigma”), with Alfasigma being the surviving entity of the merger. Alfasigma will automatically succeed by operation of law to all rights and obligations of the Merged Companies. This website will remain active until all the activities of the process relating to the transfer to Alfasigma of the drugs title to the marketing authorizations previously owned and the other products previously distributed by Alfa Wassermann S.p.A., are completed.
Please further note that pursuant to the applicable law on personal data protection, including the order of the Privacy Authority dated 8 April 2009 on “Rules Applicable to Mergers & Acquisitions” (published in the Official Gazette No. 106 of 9 May 2009), the privacy statement previously released by the Merged Companies pursuant to article 13 of Legislative Decree no. 196/2003 is updated effective from 1 August 2017 as follows:
All personal data will continue to be processed in accordance with the applicable law, the given consent (to the extent applicable), and the current contractual relationships.
An updated list of the Data Processors may be requested in writing to the Privacy Department at: email@example.com.